Organisation paid for research Program year 2024 Source: CMS Open Payments

Progressive Clinical Research P.A

Neither a doctor nor a teaching hospital

Research payments

$120,743

41 payments

Through program year 2024, Progressive Clinical Research P.A is reported as receiving $120,743 in research payments, across 41 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$33,395	14
2023	Research	$87,348	27

Breakdown

Who paid Research payments · program years 2023–2024

Arcutis Biotherapeutics, Inc. $120,743 41 payments

Studies the money was for Research payments · program years 2023–2024

A Phase 1b, Randomized, Vehicle-Controlled, Double-Blind, Pharmacokinetics, Pharmacodynamics, and Safety Study of ARQ-255 Topical Suspension in Healthy Volunteers and Subjects with Alopecia Areata $80,162 23 payments
A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.05% Administered QD in Subjects with Atopic Dermatitis $23,022 7 payments
A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.15% and ARQ-151 Cream 0.05% in Subjects with Atopic Dermatitis $7,931 8 payments
A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects with Scalp and Body Psoriasis (ARRECTOR) $6,978 1 payment
A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects with Atopic Dermatitis $2,650 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.